Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center

HIGHLIGHTS

• who: Sandrine Roux from the (UNIVERSITY) have published the paper: Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center, in the Journal: (JOURNAL)
• what: The primary reason for stopping daptomycin was completion of therapy (37 patients, 86 %).
• how: The research was conducted in accordance with the Declaration of Helsinki and national and institutional standards. Of note in this study (i) daptomycin was used as second-line b Cumulative SAE-free survival Cumulative treatment failure-free survival a 6 9 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.